Cargando…
Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease
Alzheimer’s disease (AD) is a chronic illness marked by increasing cognitive decline and nervous system deterioration. At this time, there is no known medication that will stop the course of Alzheimer’s disease; instead, most symptoms are treated. Clinical trial failure rates for new drugs remain hi...
Autores principales: | Marei, Hany E., Khan, Muhammad Umar Aslam, Hasan, Anwarul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687886/ https://www.ncbi.nlm.nih.gov/pubmed/38031028 http://dx.doi.org/10.1186/s11658-023-00504-2 |
Ejemplares similares
-
Genetically unmatched human iPSC and ESC exhibit equivalent gene expression and neuronal differentiation potential
por: Marei, Hany E., et al.
Publicado: (2017) -
Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014) -
iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017) -
iPSCs as a Platform for Disease Modeling, Drug Screening, and Personalized Therapy in Muscular Dystrophies
por: Ortiz-Vitali, Jose L., et al.
Publicado: (2019) -
Induced Pluripotent Stem Cells (iPSCs)—Roles in Regenerative Therapies, Disease Modelling and Drug Screening
por: Aboul-Soud, Mourad A. M., et al.
Publicado: (2021)